The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression

被引:59
作者
Song, C [1 ]
Earley, B [1 ]
Leonard, BE [1 ]
机构
[1] UNIV COLL GALWAY, DEPT PHARMACOL, GALWAY, IRELAND
关键词
D O I
10.1006/brbi.1996.0001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effects of subchronicly administered neuropeptide Y (NPY) intracerebroventricularly on behavioral, neurochemical, and immunological parameters were examined in sham operated and olfactory bulbectomized (OB) rats. In the untreated OB rats, an increase in ambulation, rearing, grooming, and defecation scores was found in the novel stressful environment of an ''open field.'' Following 7 days of NPY administration, these behaviors were largely attenuated. In the elevated plus-maze apparatus, OB rats showed an increase in the number of entries into the open arms and time spent on the open arms compared with sham operated animals; NPY had no significant effect on the behavior of either sham operated or OB animals in this test. A decrease in the NA concentration was found in the amygdloid cortex of OB rats. NPY infusion significantly increased the NA concentration in amygdala, reduced 5-HIAA but increased 5-HT concentrations in the hypothalamus, and increased the dopamine level in the hippocampus. NPY administration also reversed the suppression of lymphocyte proliferation in the OB rat. However, the changes in the differential white blood cell count and the elevated phytohemagglutinin-induced chemiluminescence of mononuclear cells in the OB were not altered by NPY. These results suggest that NPY may have a modulatory effect on some behavioral, neurotransmitter, and immune aspects of the OB rat model of depression. (C) 1996 Academic Press, Inc.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 72 条
[1]  
ARANGO V, 1990, SOC NEUR ABSTR, V16
[2]  
BALDESSARINI RJ, 1975, ARCH GEN PSYCHIAT, V32, P1087
[3]   DETERMINATION OF MONOAMINE AND MONOAMINE METABOLITES IN HUMAN BRAIN - POST-MORTEM STUDIES IN A GROUP OF SUICIDES AND IN A CONTROL GROUP [J].
BESKOW, J ;
GOTTFRIES, CG ;
ROOS, BE ;
WINBLAD, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1976, 53 (01) :7-20
[4]   HUMAN PSYCHONEUROIMMUNOLOGY TODAY [J].
BIONDI, M ;
KOTZALIDIS, GD .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1990, 4 (01) :22-38
[5]   IMMUNE-RESPONSE OF STRESSED RATS TREATED WITH DRUGS AFFECTING SEROTONINERGIC AND ADRENERGIC TRANSMISSION [J].
BORANIC, M ;
PERICIC, D ;
POLJAKBLAZI, M ;
MANEV, H ;
SVERKO, V ;
GABRILOVAC, J ;
RADACIC, M ;
PIVAC, N ;
MILJENOVIC, G .
BIOMEDICINE & PHARMACOTHERAPY, 1990, 44 (07) :381-387
[6]   INTRAVENTRICULAR CORTICOTROPIN-RELEASING FACTOR ENHANCES BEHAVIORAL-EFFECTS OF NOVELTY [J].
BRITTON, DR ;
KOOB, GF ;
RIVIER, J ;
VALE, W .
LIFE SCIENCES, 1982, 31 (04) :363-367
[7]   OLFACTORY PROJECTION SYSTEMS, DRUGS AND BEHAVIOR - REVIEW [J].
CAIRNCROSS, KD ;
COX, B ;
FORSTER, C ;
WREN, AF .
PSYCHONEUROENDOCRINOLOGY, 1979, 4 (03) :253-272
[8]   DAILY CHANGES OF NEUROPEPTIDE-Y-LIKE IMMUNOREACTIVITY IN THE SUPRACHIASMATIC NUCLEUS OF THE RAT [J].
CALZA, L ;
GIARDINO, L ;
ZANNI, M ;
VELARDO, A ;
PARCHI, P ;
MARRAMA, P .
REGULATORY PEPTIDES, 1990, 27 (01) :127-137
[9]   BRAIN 5-HT1 BINDING-SITES IN DEPRESSED SUICIDES [J].
CHEETHAM, SC ;
CROMPTON, MR ;
KATONA, CLE ;
HORTON, RW .
PSYCHOPHARMACOLOGY, 1990, 102 (04) :544-548
[10]   THE ANATOMY OF NEUROPEPTIDE-Y-CONTAINING NEURONS IN RAT-BRAIN [J].
CHRONWALL, BM ;
DIMAGGIO, DA ;
MASSARI, VJ ;
PICKEL, VM ;
RUGGIERO, DA ;
ODONOHUE, TL .
NEUROSCIENCE, 1985, 15 (04) :1159-1181